FDA Adverse Event Malfunction Summary report: N

ADVIA CENTAUR XP HCV ASSAY

MDR report key: 2879694 · Received December 19, 2012

Report

Report Number
1219913-2012-00411
Event Type
Malfunction
Date Received
December 19, 2012
Date of Event
November 19, 2012
Report Date
November 19, 2012
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Product Code
MZO
PMA / PMN Number
P030056
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
RS
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE CAUSE FOR THE DISCORDANT (B)(6) RESULTS WHEN COMPARED TO THE ALTERNATE METHOD IS UNKNOWN. NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED. THE IFU (113843 REV. R) THAT IS DISTRIBUTED OUTSIDE THE US STATES IN THE LIMITATIONS SECTION: "A NEGATIVE TEST RESULT DOES NOT EXCLUDE THE POSSIBILITY OF EXPOSURE TO OR INFECTION WITH (B)(6). (B)(6) ANTIBODIES MAY BE UNDETECTABLE IN SOME STAGES OF THE INFECTION AND IN SOME CLINICAL CONDITIONS." "ASSAY PERFORMANCE CHARACTERISTICS HAVE NOT BEEN ESTABLISHED WHEN THE ADVIA CENTAUR HCV ASSAY IS USED IN CONJUNCTION WITH OTHER MANUFACTURERS' ASSAYS FOR SPECIFIC (B)(6)."

Description of Event or Problem · 1

NEGATIVE ADVIA CENTAUR XP HCV RESULTS WERE OBTAINED ON A PATIENT SAMPLE. THE PATIENT SAMPLE WAS TESTED ON AN ALTERNATE METHOD AND THE RESULTS WERE (B)(6). SIMILAR RESULTS WERE OBTAINED FOR A SECOND PATIENT. IT IS UNKNOWN IF PATIENT TREATMENT WAS ALTERED OR PRESCRIBED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT ADVIA CENTAUR XP HCV RESULT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ADVIA CENTAUR XP HCV ASSAY HEPATITIS C VIRUS (ANTI-HCV) ASSAY MZO SIEMENS HEALTHCARE DIAGNOSTICS, INC. N/A UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1